PHASE I/II STUDY OF GEMCITABINE, AN ACTIVE AGENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

FOSSELLA, F.V., LIPPMAN, S.M., & TARASAOFF, P.. (1995). PHASE I/II STUDY OF GEMCITABINE, AN ACTIVE AGENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) . PROCEEDING OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY, 14(-), 371-371. SID. https://sid.ir/paper/548384/en

FOSSELLA F.V., LIPPMAN S.M., TARASAOFF P.. PHASE I/II STUDY OF GEMCITABINE, AN ACTIVE AGENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) . PROCEEDING OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY[Internet]. 1995;14(-):371-371. Available from: https://sid.ir/paper/548384/en

F.V. FOSSELLA, S.M. LIPPMAN, and P. TARASAOFF, “PHASE I/II STUDY OF GEMCITABINE, AN ACTIVE AGENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) ,” PROCEEDING OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY, vol. 14, no. -, pp. 371–371, 1995, [Online]. Available: https://sid.ir/paper/548384/en